Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06189495
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-01-03
First Post:
2023-11-13
Brief Title:
A Randomized Double-blind Placebo-controlled Phase II Clinical Study to Evaluate the Safety Tolerability Efficacy and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
Sponsor:
Changchun GeneScience Pharmaceutical Co Ltd
Organization:
Changchun GeneScience Pharmaceutical Co Ltd
Organization Data
Organization:
Changchun GeneScience Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
GenSci048-204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Changchun GeneScience Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| West China Hospital | OTHER |